Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Catherine L. Tan
Introduction
Catherine L. Tan is a remarkable inventor based in Boston, MA, recognized for her significant contributions to the field of immunology. With one patent to her name, she has made strides in understanding and regulating immune responses, which has implications for therapeutic approaches in various diseases.
Latest Patents
Catherine's patent, titled "Regulatory T cell PD-1 modulation for regulating T cell effector immune responses," focuses on innovative methods of modulating the expression and activity of PD-1 in regulatory T cells (Tregs). This invention aims to enhance the regulation of effector immune responses in effector T cells (Teffs), indicating its potential for advancing treatments in immunological disorders.
Career Highlights
Throughout her career, Catherine has worked at prestigious institutions such as Harvard College and The Brigham and Women's Hospital, Inc. These affiliations highlight her commitment to advancing medical research and her role in the academic and clinical landscape of immunology.
Collaborations
Catherine has collaborated with notable professionals in her field, including esteemed colleagues Arlene Helen Sharpe and Gordon James Freeman. Their teamwork signifies the strength of interdisciplinary collaboration in driving innovative solutions within the realm of immune response regulation.
Conclusion
Catherine L. Tan's work exemplifies the impact of innovative thinking in science and medicine. Her patent on PD-1 modulation reflects a significant advancement in immunology, showcasing her contributions to understanding and potentially transforming immune therapeutic strategies. As the field continues to evolve, inventors like Catherine pave the way for future breakthroughs.